Moberg Pharma publishes prospectus relating to the rights issue
Moberg Pharma publishes prospectus relating to the rights issueMoberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) announces that the prospectus relating to the Company’s rights issue of ordinary shares (the “Rights Issue”) has been approved and registered...